Non-small cell lung cancer
J Skřičková, B Kadlec, O Venclíček - Vnitrni Lekarstvi, 2018 - europepmc.org
Non-small cell lung cancer (NSCLC) represents 80% of diseases considering all patients with
lung cancer. NSCLC comprises all histological types except for the small cell cancer. The …
lung cancer. NSCLC comprises all histological types except for the small cell cancer. The …
Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry
O Venclicek, J Skrickova, K Brat, O Fischer… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: LUCAS is a clinical lung cancer registry ( ClinicalTrials.gov identifier is
NCT04228237 ), prospectively collecting data from newly diagnosed lung cancer patients in …
NCT04228237 ), prospectively collecting data from newly diagnosed lung cancer patients in …
A simple dilute-and-shoot procedure for the determination of platinum in human pleural effusions using HR-CS GF-AAS
O Zvěřina, O Venclíček, J Kuta, P Coufalík… - Journal of Trace …, 2021 - Elsevier
Background High-resolution continuum source AAS is an emerging technique for the
determination of trace elements in clinical analysis. We aimed to develop a method for the direct …
determination of trace elements in clinical analysis. We aimed to develop a method for the direct …
Laboratory parameters associated with inflammation do not affect PD-L1 expression in non-small cell lung cancer
…, O Fischer, M Marel, M Hrnciarik, O Venclicek… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Due to some interconnectedness at the molecular level, this study assessed
the possible influence of laboratory parameters associated with systemic inflammatory …
the possible influence of laboratory parameters associated with systemic inflammatory …
[HTML][HTML] Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer
…, M Marel, M Hrnciarik, O Venclicek… - Translational Cancer …, 2022 - ncbi.nlm.nih.gov
Background Programmed death-ligand 1 (PD-L1) expression is a standard predictor in the
selection of immunotherapy for locally advanced/advanced non-small cell lung cancer (…
selection of immunotherapy for locally advanced/advanced non-small cell lung cancer (…
[PDF][PDF] Nemalobuněčný karcinom plic
J Skřičková, B Kadlec, O Venclíček - Vnitřní lékařství, 2017 - casopisvnitrnilekarstvi.cz
Nonsmall cell lung cancer (NSCLC) represents 80% of diseases considering all patients with
lung cancer. NSCLC comprises all histological types except for the small cell cancer. The …
lung cancer. NSCLC comprises all histological types except for the small cell cancer. The …
[BOOK][B] Základy moderní pneumoonkologie
J Skřičková, V Kolek, Z Adam, Z Bortlíček, P Brabec… - 2012 - is.muni.cz
Nádory plic, pleury a mediastina představují jedno z nejvýznamnějších témat pro pneumology,
onkology, chirurgy, radioterapeuty, internisty, praktické lékaře, odborníky paliativní …
onkology, chirurgy, radioterapeuty, internisty, praktické lékaře, odborníky paliativní …
[HTML][HTML] Worse Prognosis in the Symptomatic Patients With Lung Cancer–Czech Multicentric Study
…, Z Chladkova, LFC Mendez, O Venclicek… - Cancer Diagnosis & …, 2022 - ncbi.nlm.nih.gov
Results The most common symptoms were cough (47.5%), dyspnea (45.6%), pain (27.3%),
and weight loss (25.7%). Among all patients, 16% were asymptomatic. We demonstrated the …
and weight loss (25.7%). Among all patients, 16% were asymptomatic. We demonstrated the …
Epidermal growth factor receptor (EGFR) gene mutation testing prior to tyrosine kinase inhibitors (TKI) treatment–prospective data from the Czech TULUNG registry
J Skřičková, P Májková, M Bařinová, M Bratová… - 2020 - Eur Respiratory Soc
Study evaluated the frequency of individual mutations before the start of the 1st and 2nd
generation TKI treatment, and determined in what material the mutations were identified and …
generation TKI treatment, and determined in what material the mutations were identified and …
P3. 02b-030 Single Institution Experience with EGFR Gene Mutation Analysis and Treatment of EGFR Positive Patients in the Years 2010 to 2015: Topic: EGFR …
O Venclíček, P Venclíčková, J Skřičková… - Journal of Thoracic …, 2017 - jto.org
Background Our department is among several centers in the Czech Republic which
comprehensively diagnose and treat patients with lung cancer, including mutational analysis of …
comprehensively diagnose and treat patients with lung cancer, including mutational analysis of …